Xingyu Dong

461 total citations
7 papers, 106 citations indexed

About

Xingyu Dong is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Xingyu Dong has authored 7 papers receiving a total of 106 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Physiology. Recurrent topics in Xingyu Dong's work include Alzheimer's disease research and treatments (2 papers), RNA modifications and cancer (1 paper) and Infectious Diseases and Tuberculosis (1 paper). Xingyu Dong is often cited by papers focused on Alzheimer's disease research and treatments (2 papers), RNA modifications and cancer (1 paper) and Infectious Diseases and Tuberculosis (1 paper). Xingyu Dong collaborates with scholars based in China and United States. Xingyu Dong's co-authors include Ruxiang Xu, Qingshan Deng, Ruen Liu, Danyan Li, Ying Xing, Ruxiang Xu, Maoying Zhang, Weiqiang Jia, Wang Wang and Melitta Schachner and has published in prestigious journals such as Neuropsychopharmacology, Neurochemical Research and International Immunopharmacology.

In The Last Decade

Xingyu Dong

5 papers receiving 103 citations

Peers

Xingyu Dong

MB

GENET

PHYSI

DN

ONCOL

Jingwen Si China

Jiangong Ren China

Shoumeng Han China

Umer Javed Butt Germany

Camelia Monoranu Germany

Niandong Zheng China

Steven Rodriguez United States

Longxiang Sheng China

Dallas McDonald United States

Tatiana Lipman Canada

Jingwen Si China

Xingyu Dong

70 ×1.1

MB

20 ×0.7

GENET

35 ×1.7

PHYSI

10 ×0.6

DN

24 ×1.5

ONCOL

Citations per year, relative to Xingyu Dong Xingyu Dong (= 1×) peers Jingwen Si

Countries citing papers authored by Xingyu Dong

Since Specialization

Citations

This map shows the geographic impact of Xingyu Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingyu Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingyu Dong more than expected).

Fields of papers citing papers by Xingyu Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingyu Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingyu Dong. The network helps show where Xingyu Dong may publish in the future.

Co-authorship network of co-authors of Xingyu Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xingyu Dong. A scholar is included among the top collaborators of Xingyu Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingyu Dong. Xingyu Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Fu, Yu, Jing Xi, Jia-Yi Dong, et al.. (2025). Immunomodulatory mechanisms and comprehensive treatment strategies of traditional Chinese medicine for enhancing diabetic foot ulcer healing. International Immunopharmacology. 164. 115381–115381.

2.

Zeng, Xin-Xin I., Fei Wang, Yuhang Wu, et al.. (2025). The safety of pyrazinamide in pediatric drug-sensitive tuberculosis treatment: A real-world study. Journal of Infection and Public Health. 19(1). 103022–103022.

3.

Li, Baikun, Xingyu Dong, Ji‐Min Zhu, et al.. (2021). Crosstalk between H1975 tumor cells and platelets to induce the proliferation, migration and tube formation of vascular endothelial cells. Oncology Letters. 22(3). 676–676. 4 indexed citations

4.

Zheng, Xiaoyu, Xingyu Dong, Qingshan Deng, et al.. (2017). Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice. Neurochemical Research. 42(8). 2191–2207. 28 indexed citations

5.

Deng, Qingshan, Xingyu Dong, Hao Wu, et al.. (2015). Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels. Neuropsychopharmacology. 41(2). 440–453. 20 indexed citations

6.

Dong, Xingyu, Qingshan Deng, Xiaohu Nie, et al.. (2015). Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma. Experimental and Molecular Pathology. 98(2). 192–199. 18 indexed citations

7.

Xu, Ruxiang, et al.. (2015). Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin–proteasome pathway. Drug Design Development and Therapy. 9. 5611–5611. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact